| Product Code: ETC12838678 | Publication Date: Apr 2025 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
In 2024, Portugal continued to rely on key European countries such as Germany, Spain, Belgium, Metropolitan France, and the Netherlands for its influenza medication imports. With a low Herfindahl-Hirschman Index (HHI) indicating low market concentration, the market remains competitive. The compound annual growth rate (CAGR) from 2020 to 2024 was steady at 2.5%, with a notable growth rate of 2.21% in 2023-24. This indicates a stable and growing market for influenza medications in Portugal, with diverse sources of imports contributing to its availability and accessibility.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Portugal Influenza Medications Market Overview |
3.1 Portugal Country Macro Economic Indicators |
3.2 Portugal Influenza Medications Market Revenues & Volume, 2022 & 2032F |
3.3 Portugal Influenza Medications Market - Industry Life Cycle |
3.4 Portugal Influenza Medications Market - Porter's Five Forces |
3.5 Portugal Influenza Medications Market Revenues & Volume Share, By Drug Type, 2022 & 2032F |
3.6 Portugal Influenza Medications Market Revenues & Volume Share, By Route of Administration, 2022 & 2032F |
3.7 Portugal Influenza Medications Market Revenues & Volume Share, By Patient Age Group, 2022 & 2032F |
4 Portugal Influenza Medications Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of influenza cases in Portugal |
4.2.2 Growing awareness about the importance of early treatment for influenza |
4.2.3 Technological advancements in influenza medications development |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for new influenza medications |
4.3.2 Competition from alternative treatments such as home remedies and natural therapies |
5 Portugal Influenza Medications Market Trends |
6 Portugal Influenza Medications Market, By Types |
6.1 Portugal Influenza Medications Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Portugal Influenza Medications Market Revenues & Volume, By Drug Type, 2022 - 2032F |
6.1.3 Portugal Influenza Medications Market Revenues & Volume, By Antiviral Drugs (Oseltamivir, Zanamivir, Peramivir, Baloxavir), 2022 - 2032F |
6.1.4 Portugal Influenza Medications Market Revenues & Volume, By Symptom Relief Medications (Pain Relievers, Decongestants, Antihistamines), 2022 - 2032F |
6.2 Portugal Influenza Medications Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Portugal Influenza Medications Market Revenues & Volume, By Oral, 2022 - 2032F |
6.2.3 Portugal Influenza Medications Market Revenues & Volume, By Intravenous (IV), 2022 - 2032F |
6.2.4 Portugal Influenza Medications Market Revenues & Volume, By Inhalation, 2022 - 2032F |
6.3 Portugal Influenza Medications Market, By Patient Age Group |
6.3.1 Overview and Analysis |
6.3.2 Portugal Influenza Medications Market Revenues & Volume, By Pediatric, 2022 - 2032F |
6.3.3 Portugal Influenza Medications Market Revenues & Volume, By Adult, 2022 - 2032F |
6.3.4 Portugal Influenza Medications Market Revenues & Volume, By Geriatric, 2022 - 2032F |
7 Portugal Influenza Medications Market Import-Export Trade Statistics |
7.1 Portugal Influenza Medications Market Export to Major Countries |
7.2 Portugal Influenza Medications Market Imports from Major Countries |
8 Portugal Influenza Medications Market Key Performance Indicators |
8.1 Number of reported influenza cases in Portugal |
8.2 Adoption rate of new influenza medications in the market |
8.3 Research and development investments in influenza medication technologies. |
9 Portugal Influenza Medications Market - Opportunity Assessment |
9.1 Portugal Influenza Medications Market Opportunity Assessment, By Drug Type, 2022 & 2032F |
9.2 Portugal Influenza Medications Market Opportunity Assessment, By Route of Administration, 2022 & 2032F |
9.3 Portugal Influenza Medications Market Opportunity Assessment, By Patient Age Group, 2022 & 2032F |
10 Portugal Influenza Medications Market - Competitive Landscape |
10.1 Portugal Influenza Medications Market Revenue Share, By Companies, 2025 |
10.2 Portugal Influenza Medications Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here